Molecular Imaging in the Era of Personalized Medicine
暂无分享,去创建一个
[1] Eun Jeong Lee,et al. Annexin V Imaging Detects Diabetes-Accelerated Apoptosis and Monitors the Efficacy of Benfotiamine Treatment in Ischemic Limbs of Mice , 2014, Molecular imaging.
[2] Wolfgang A Weber,et al. Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning , 2008, Nature Clinical Practice Oncology.
[3] Yasuyoshi Watanabe,et al. [Molecular imaging for drug development]. , 2007, Brain and nerve = Shinkei kenkyu no shinpo.
[4] M. Verheij,et al. Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Kyung-Han Lee,et al. Radiolabeled RGD uptake and alphav integrin expression is enhanced in ischemic murine hindlimbs. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] Rebecca Richards-Kortum,et al. Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics. , 2012, Nanomedicine.
[7] E. Ritman,et al. Molecular imaging in small animals—roles for micro‐CT , 2002, Journal of cellular biochemistry. Supplement.
[8] Harvey R Herschman,et al. Molecular Imaging: Looking at Problems, Seeing Solutions , 2003, Science.
[9] A. Haimovitz-Friedman,et al. Anticancer therapy and apoptosis imaging. , 2012, Experimental oncology.
[10] Julie Hoggatt,et al. Personalized medicine--trends in molecular diagnostics: exponential growth expected in the next ten years. , 2011, Molecular diagnosis & therapy.
[11] Kyung-Han Lee,et al. Targeted in vivo imaging of angiogenesis: present status and perspectives. , 2007, Current pharmaceutical design.
[12] Neal Rosen,et al. Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors , 2004, Nature Biotechnology.
[13] Hedvig Hricak,et al. Molecular imaging for personalized cancer care , 2012, Molecular oncology.
[14] Kyung-Han Lee,et al. 99mTc-Hydrazinonicotinamide Epidermal Growth Factor–Polyethylene Glycol–Quantum Dot Imaging Allows Quantification of Breast Cancer Epidermal Growth Factor Receptor Expression and Monitors Receptor Downregulation in Response to Cetuximab Therapy , 2011, The Journal of Nuclear Medicine.
[15] Thomas E Yankeelov,et al. Magnetic resonance in the era of molecular imaging of cancer. , 2011, Magnetic resonance imaging.
[16] Andrei Iagaru,et al. Imaging tumor angiogenesis: the road to clinical utility. , 2013, AJR. American journal of roentgenology.
[17] G. Ginsburg,et al. The path to personalized medicine. , 2002, Current opinion in chemical biology.
[18] Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] Kimberly A Kelly,et al. Techniques for Molecular Imaging Probe Design , 2011, Molecular imaging.
[20] David A Mankoff,et al. Tumor Receptor Imaging , 2008, Journal of Nuclear Medicine.
[21] R. Djaldetti,et al. Assessment of response of brain metastases to radiotherapy by PET imaging of apoptosis with 18F-ML-10 , 2012, European Journal of Nuclear Medicine and Molecular Imaging.